Recherche
-
Contribution of alcohol use in HIV/hepatitis C virus co-infection to all-cause and cause-specific mortality: A collaboration of cohort studies.
(Journal of Viral Hepatitis. vol. 30, n° 9, pp. 775-786, 2023-06-20)Article de revueLibre accès -
CytOpT: Optimal transport with domain adaptation for interpreting flow cytometry data
(Annals of Applied Statistics. vol. 17, n° 2, pp. 1086-1104, 2023-06-01)Article de revueLibre accès -
Estimating the population effectiveness of interventions against COVID-19 in France: A modelling study
(Epidemics. vol. 46, pp. 100744, 2024-03-01)Article de revueLibre accès -
All-cause hospitalisation among people living with HIV according to gender, mode of HIV acquisition, ethnicity, and geographical origin in Europe and North America: findings from the ART-CC cohort collaboration
(Lancet Public Health. vol. 8, n° 10, pp. 776-787, 2023-10)Article de revueLibre accès -
A framework for the definition and interpretation of the use of surrogate endpoints in interventional trials
(EClinicalMedicine. vol. 65, pp. 102283, 2023-11)Article de revueLibre accès -
All-cause mortality before and after DAA availability among people living with HIV and HCV: An international comparison between 2010 and 2019
(International Journal of Drug Policy. vol. 124, pp. 104311, 2024-01-06)Article de revue -
Estimation of Improvements in Mortality in Spectrum Among Adults With HIV Receiving Antiretroviral Therapy in High-Income Countries
(Journal of Acquired Immune Deficiency Syndromes - JAIDS. vol. 95, n° 1S, pp. e89-e96, 2024-01-01)Article de revueLibre accès -
Changes in incidence of hepatitis C virus reinfection and access to direct-acting antiviral therapies in people with HIV from six countries, 2010-19: an analysis of data from a consortium of prospective cohort studies
(Lancet HIV. vol. 11, n° 2, pp. e106-e116, 2024-01-12)Article de revue -
Humoral response after mRNA COVID-19 primary vaccination and single booster dose in people living with HIV compared to controls: a French nationwide multicenter cohort study - ANRS0001s COV-POPART
(International Journal of Infectious Diseases. vol. 146, pp. 107110, 2024-05-31)Article de revueLibre accès -
Definition of Virological Endpoints Improving the Design of Human Immunodeficiency Virus (HIV) Cure Strategies Using Analytical Antiretroviral Treatment Interruption
(Clinical Infectious Diseases. pp. ciae235, 2024-05-31)Article de revue